ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 7 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $724,000 | -45.0% | 418,671 | -2.4% | 0.00% | 0.0% |
Q2 2019 | $1,317,000 | -28.3% | 428,975 | -3.0% | 0.00% | -50.0% |
Q1 2019 | $1,836,000 | +3.3% | 442,194 | -1.8% | 0.00% | 0.0% |
Q4 2018 | $1,778,000 | -48.6% | 450,133 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $3,457,000 | -12.7% | 450,133 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $3,961,000 | – | 450,133 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 1,194,070 | $3,940,000 | 2.71% |
Sio Capital Management, LLC | 1,488,508 | $4,912,000 | 1.22% |
MANGROVE PARTNERS IM, LLC | 2,514,576 | $8,298,000 | 0.85% |
KNOTT DAVID M | 478,186 | $1,578,000 | 0.56% |
Logos Global Management LP | 2,000,000 | $6,600,000 | 0.56% |
DAFNA Capital Management LLC | 677,500 | $2,236,000 | 0.47% |
Vivo Capital, LLC | 2,840,909 | $9,375,000 | 0.41% |
SABBY MANAGEMENT, LLC | 765,276 | $2,525,000 | 0.36% |
MYDA Advisors LLC | 211,165 | $697,000 | 0.17% |
Parkman Healthcare Partners LLC | 225,881 | $745,000 | 0.16% |